In adjusted analyses, having a metabolic disorder was identified as a risk factor for DILI (adjusted HR [aHR], 2.85; 95% CI, 1.01–8.07; P = .042), along with serum albumin <3.5 g/dL (aHR, 2.26; 95% CI, 1.29–3.96; P = .005) (Table 2). The gene discussed is ALB; the disease is metabolic disease.